These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24706611)

  • 1. Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
    Ali T; Nakajima T; Sano K; Sato K; Choyke PL; Kobayashi H
    Contrast Media Mol Imaging; 2014; 9(4):276-82. PubMed ID: 24706611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.
    Tang Q; Nagaya T; Liu Y; Lin J; Sato K; Kobayashi H; Chen Y
    J Control Release; 2017 Aug; 260():154-163. PubMed ID: 28601576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
    Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
    BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
    Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
    Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Cancer Sci; 2021 Mar; 112(3):1326-1330. PubMed ID: 33543819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo.
    Tang Q; Nagaya T; Liu Y; Horng H; Lin J; Sato K; Kobayashi H; Chen Y
    J Control Release; 2018 Jun; 279():171-180. PubMed ID: 29673644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.
    Nakajima T; Sano K; Choyke PL; Kobayashi H
    Theranostics; 2013; 3(6):357-65. PubMed ID: 23781283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near infrared photoimmunotherapy of B-cell lymphoma.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
    Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
    Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
    Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
    Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.